Rohto Financial Statements From 2010 to 2026
| RPHCFDelisted Stock | USD 14.72 0.00 0.00% |
Check Rohto Pharmaceutical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Rohto Pharmaceutical's main balance sheet or income statement drivers, such as , as well as many indicators such as . Rohto financial statements analysis is a perfect complement when working with Rohto Pharmaceutical Valuation or Volatility modules.
Rohto |
Rohto Pharmaceutical CoLtd Company Return On Equity Analysis
Rohto Pharmaceutical's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current Rohto Pharmaceutical Return On Equity | 0.13 |
Most of Rohto Pharmaceutical's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Rohto Pharmaceutical CoLtd is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
CompetitionBased on the latest financial disclosure, Rohto Pharmaceutical CoLtd has a Return On Equity of 0.125. This is 95.27% lower than that of the Consumer Defensive sector and 99.15% lower than that of the Household & Personal Products industry. The return on equity for all United States stocks is 140.32% lower than that of the firm.
Rohto Pharmaceutical Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Rohto Pharmaceutical's current stock value. Our valuation model uses many indicators to compare Rohto Pharmaceutical value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Rohto Pharmaceutical competition to find correlations between indicators driving Rohto Pharmaceutical's intrinsic value. More Info.Rohto Pharmaceutical CoLtd is currently regarded as top stock in return on equity category among its peers. It also is currently regarded as top stock in return on asset category among its peers reporting about 0.56 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Rohto Pharmaceutical CoLtd is roughly 1.80 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Rohto Pharmaceutical's earnings, one of the primary drivers of an investment's value.About Rohto Pharmaceutical Financial Statements
Rohto Pharmaceutical stakeholders use historical fundamental indicators, such as Rohto Pharmaceutical's revenue or net income, to determine how well the company is positioned to perform in the future. Although Rohto Pharmaceutical investors may analyze each financial statement separately, they are all interrelated. For example, changes in Rohto Pharmaceutical's assets and liabilities are reflected in the revenues and expenses on Rohto Pharmaceutical's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Rohto Pharmaceutical CoLtd. Please read more on our technical analysis and fundamental analysis pages.
,Ltd. manufactures and markets pharmaceutical products, cosmetics, and functional foods worldwide. ,Ltd. was founded in 1899 and is headquartered in Osaka, Japan. Rohto Pharmaceutical operates under Household Personal Products classification in the United States and is traded on OTC Exchange. It employs 6866 people.
Currently Active Assets on Macroaxis
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment. You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.
Other Consideration for investing in Rohto Pink Sheet
If you are still planning to invest in Rohto Pharmaceutical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Rohto Pharmaceutical's history and understand the potential risks before investing.
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios |